Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model

Human Reproduction

Volumn 26, Issue 6, 2011, Pages 1362-1370

  Colette, S ^a   Defrere S ^a   Lousse, J C ^a   Van Langendonckt, A ^a   Gotteland, J P ^b   Loumaye, E ^b   Donnez, J ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b PregLem   (Switzerland)

Author keywords

endometriosis; estradiol sulfamate; heterologous murine model; steroid sulfatase; steroid sulfatase inhibitor

Indexed keywords

ENZYME INHIBITOR; ESTRADIOL; ESTRADIOL 3 O SULFAMATE; PROGESTERONE RECEPTOR; STERYL SULFATASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EDEMA; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME INHIBITION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LIVER; MORPHOMETRICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STROMA EDEMA; UTERUS;

ANIMALIA; MURINAE; MUS;

EID: 79957466515     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der079     Document Type: Article

References (41)

1. Absenger Y, Hess-Stumpp H, Kreft B, Krätzschmar J, Haendler B, Schütze N, Regidor PA, Winterhager E. Cyr61, a deregulated gene in endometriosis. Mol Hum Reprod 2004;10:399-407. (Pubitemid 38714372)
2. Bauer K, Elger W, Schneider B, Krahl E, Bauer R. Effect of estradiol sulfamate (ES-J995) on affinity of haemoglobin for oxygen, cardiovascular function and acid-base balance in ovariectomized rats. Exp Toxicol Pathol 2003;55:301-307. (Pubitemid 38004958)
3. Bulun SE, Cheng YH, Pavone ME, Yin P, Imir G, Utsunomiya H, Thung S, Xue Q, Marsh EE, Tokunaga H et al. 17beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:44-50.
4. Carlström K, Bergqvist A, Ljungberg O. Metabolism of estrone sulphate in endometriotic tissue and in uterine endometrium in proliferative and secretory cycle phase. Fertil Steril 1988;49:229-233. (Pubitemid 18047815)
5. Chander SK, Purohit A,Woo LW, Potter BV, Reed MJ. The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates. Biochem Biophys Res Commun 2004;322:217-222. (Pubitemid 39099257)
6. Colette S, Donnez J. Endometriosis. N Engl J Med 2009;360:1911-1912.
7. Colette S, Lousse JC, Defrére S, Curaba M, Heilier JF, Van Langendonckt A, Mestdagt M, Foidart JM, Loumaye E, Donnez J. Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod 2009a;24:2133-2141.
8. Colette S, Defrére S, Lousse JC, Van Langendonckt A, Loumaye E, Donnez J. Evaluation of estrogen treatment in an immunodeficient mouse endometriosis model. Gynecol Obstet Invest 2009b;68:262-268.
9. Conley A, Hinshelwood M. Mammalian aromatases. Reproduction 2001; 121:685-695. (Pubitemid 32472054)
10. Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, Husen B, Thole H, Dunselman G, Groothuis P. Estrogen-metabolizing enzymes in endometrium and endometriosis.
11. Defrére S, Van Langendonckt A, Gonzalez-Ramos R, Jouret M, Mettlen M, Donnez J. Quantification of endometriotic lesions in a murine model by fluorimetric and morphometric analyses. Hum Reprod 2006a;21:810-817. (Pubitemid 43378901)
12. Defrére S, Van Langendonckt A, Vaesen S, Jouret M, Gonzalez-Ramos R, Gonzalez D, Donnez J. Iron overload enhances epithelial cell proliferation in endometriotic lesions induced in a murine model. Hum Reprod 2006b;21:2810-2816. (Pubitemid 44566991)
13. Delvoux B, Groothuis P, D'Hooghe T, Kyama C, Dunselman G, Romano A. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 2009;94:876-883.
14. Elger W, Schwarz S, Hedden A, Reddersen G, Schneider B. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J Steroid Biochem Mol Biol 1995;55:395-403. (Pubitemid 26022205)
15. ElgerW, Barth A, Hedden A, Reddersen G, Ritter P, Schneider B, Züchner J, Krahl E, Müller K, Oettel M et al. Estrogen sulfamates: A new approach to oral estrogen therapy. Reprod Fertil Dev 2001;13:297-305. (Pubitemid 33133348)
16. Ezaki K, Motoyama H, Sasaki H. Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol 2001;98:815-819. (Pubitemid 33042550)
17. Gonzalez-Ramos R, Van Langendonckt A, Defrére S, Lousse JC, Mettlen M, Guillet A, Donnez J. Agents blocking the nuclear factor-kappa B pathway are effective inhibitors of endometriosis in an in vivo experimental model. Gynecol Obstet Invest 2007;65:174-186. (Pubitemid 351562920)
18. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-1481. (Pubitemid 29220854)
19. Howarth NM, Purohit A, Reed MJ, Potter BV. Estrone sulfamates: Potent inhibitors of estrone sulfatase with therapeutic potential. J Med Chem 1994;37:219-221. (Pubitemid 24063038)
20. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: The pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2003;83:149-155. (Pubitemid 37040651)
21. MacCarthy-Morrogh L, Townsend PA, Purohit A, Hejaz HAM, Potter BVL, Reed MJ, Packham G. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells. Cancer Res 2000; 60:5441-5450.
22. Nisolle M, Casanas-Roux F, Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 1997;68:912-919. (Pubitemid 27506110)
23. Nisolle M, Casanas-Roux F, Donnez J. Early-stage endometriosis: Adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril 2000;74:306-312. (Pubitemid 30604195)
24. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
25. Nussbaumer P, Billich A. Steroid sulfatase inhibitors. Med Res Rev 2004; 24:529-576. (Pubitemid 38802700)
26. Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: A review. Biochim Biophys Acta 2004;1654:123-143. (Pubitemid 38681205)
27. Purohit A, Williams GJ, Roberts CJ, Potter BV, Reed MJ. In vivo inhibition of oestrone sulfatase and dehydroepiandrosterone sulfatase by oestrone-3-O-sulfamate. Int J Cancer 1995;63:106-111.
28. Purohit A, Fusi L, Brosens J, Woo LWL, Potter BVL, Reed MJ. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: A potential new therapy. Hum Reprod 2008; 23:290-297. (Pubitemid 351651236)
29. Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV. Steroid sulfatase: Molecular biology, regulation, and inhibition. Endocr Rev 2005; 26:171-202.
30. Rizner TL. Etsrogen metabolism and action in endometriosis. Mol Cell Endocrinol 2009;307:8-18.
31. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-230. (Pubitemid 37412561)
32. Smuc T, Ribic Pucelj M, Sinkovec J, Husen B, Thole H, Nanisnik Rizner T. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol 2007; 23:105-111. (Pubitemid 46481023)
33. Smuc T, Hevir N, Ribic?-Pucelj M, Husen B, Thole H, Riz?ner TL. Disturbed estrogen and progesterone action in ovarian endometriosis. Mol Cell Endocrinol 2009;301:59-64.
34. Stanway SJ, Purohit A, Woo LW, Sufi S, Vigushin D, Ward R, Wilson RH, Stanczyk FZ, Dobbs N, Kulinskaya E et al. Phase I study of STX 64 (667 Coumate) in breast cancer patients: The first study of a steroid sulfatase inhibitor. Clin Cancer Res 2006;12:1585-1592.
35. Utsunomiya H, Ito K, Suzuki T, Kitamura T, Kaneko C, Nakata T, Niikura H, Okamura K, Yaegashi N, Sasano H. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clin Cancer Res 2004;10:5850-5856. (Pubitemid 39180965)
36. Van Langendonckt A, Casanas-Roux F, Eggermont J, Donnez J. Characterization of iron deposition in endometriotic lesions induced in the nude mouse model. Hum Reprod 2004;19:1265-1271. (Pubitemid 38807695)
37. Wolff B, Billich A, Brunowsky W, Herzig G, Lindley I, Nussbaumer P, Pursch E, Rabeck C, Winkler G. Microtiter plate cellular assay for human steroid sulfatase with fluorescence readout. Anal Biochem 2003;318:276-284. (Pubitemid 36694120)
38. Yamamoto T, Noguchi T, Tamura T, Kitawaki J, Okada H. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 1993; 169:734-738. (Pubitemid 23290202)
39. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: Failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 1998;83:4474-4480. (Pubitemid 29100154)
40. Zhang B, Chen D, Wang G, Wu Y. Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and human endometrial cells. J Huazhong Univ Sci Technolog Med Sci 2003;23:283-285.
41. Zhang H, Zhao X, Liu S, Li J, Wen Z, Li M. 17bE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkB-dependent pathway. Mol Cell Endocrinol 2010;317:31-43.